Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$520,946
-$144,044 QoQ
Shares Held
21,634
-8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,728
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MJP ASSOCIATES INC /ADV holds $12,749,028 across 8 Drug Manufacturers - General names. PFE ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,834 | $4,598,615 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,086 | $2,067,051 | |
| 3 | ABBV |
AbbVie Inc.
|
8,151 | $2,051,117 | |
| 4 | JNJ |
Johnson & Johnson
|
7,837 | $1,990,362 | |
| 5 | AMGN |
Amgen Inc
|
2,286 | $827,806 | |
| 6 | PFE |
Pfizer Inc
This page
|
21,634 | $520,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,940 | $371,439 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,583 | $321,692 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,946 | 21,634 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $664,990 | 23,682 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $576,111 | 23,137 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $601,429 | 23,604 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $481,745 | 19,874 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $430,197 | 16,977 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $393,280 | 14,824 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $432,421 | 14,942 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $433,857 | 15,506 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $447,940 | 16,142 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $398,943 | 13,857 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $302,112 | 9,108 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $729,418 | 19,886 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $885,196 | 21,696 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,137,937 | 22,208 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $924,780 | 21,133 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,167,406 | 22,266 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,028,152 | 19,860 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,148,994 | 19,458 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $703,729 | 16,362 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $628,635 | 16,053 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $520,842 | 14,376 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $477,609 | 12,975 | Shares | Sole | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||